Patent US4259313A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4259313A Expired / Lapsed US ⏱️ 0.0 years remaining

Fluorescent labels

Assignee: Clinical Diagnostic Systems Inc
•
Filing: 1979-08-16
•
Granted: 1981-03-31
•
Expires: 1999-08-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are described stabilized fluorescent labels comprising rare earth chelate incorporated in polymeric beads derived from a latex. Labeled reactive proteinaceous species such as labeled immunoreagents comprising the stabilized fluorescent labels having protein absorbed or covalently bonded thereto are also described.

Inventors

  • 👤 David S. Frank
  • 👤 Michael W. Sundberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 05:16
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/585; G01N33/53; G01N33/531; G01N33/532; G01N33/533; Y; Y10; Y10S; Y10S436/00; Y10S436/80

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 128 words
A composition comprising protein adsorbed or covalently bound to an aqueous-stabilized fluorescent label comprising a fluorescent rare earth chelate incorporated into a polymeric bead which is derived from a loaded latex wherein said rare earth chelate comprises up to about 7.5 percent by weight of said beads and said loaded latex has a polymeric discontinuous phase which consists essentially of polymer polymerized from one or more ethenic monomers and has an aqueous continuous phase and exhibits essentially no visible coagulation or settling out when 250 ml of the latex containing from about 10 to about 20 weight percent dispersed phase is stirred at 25° C. into an equal volume of acetone over a 1 minute period and subsequently allowed to stand at about 25° C. for 10 minutes.
Claim 2
Dependent Claim 128 words
A composition comprising protein adsorbed or covalently bound to an aqueous-stabilized fluorescent label comprising a fluorescent rare earth chelate incorporated into a polymeric bead which is derived from a loaded latex wherein said rare earth chelate comprises up to about 7.5 percent by weight of said beads and said loaded latex has a polymeric discontinuous phase which consists essentially of polymer polymerized from one or more ethenic monomers and has an aqueous continuous phase and exhibits essentially no visible coagulation or settling out when 250 ml of the latex containing from about 10 to about 20 weight percent dispersed phase is stirred at 25° C. into an equal volume of acetone over a 1 minute period and subsequently allowed to stand at about 25° C. for 10 minutes.
Claim 3
Dependent Claim 19 words
The composition of claim 1 wherein said protein is selected from the group consisting of antibodies, antigens, and enzymes.
Claim 4
Dependent Claim 18 words
The composition of claim 1 wherein said protein is selected from the group consisting of antigens and antibodies.
Claim 5
Dependent Claim 36 words
The composition of claim 3 wherein the polymeric bead comprises a member selected from the group consisting of poly(n-butyl acrylate-co-styrene-co-2-acrylamido-2-methylpropanesulfonic acid, poly(n-butyl acrylate-co-2-acrylamido-2-methylpropanesulfonic acid, poly[styrene-co-(2-chloroethylsulfonylmethyl)styrene-co-2-acrylamido-2-methylpropanesulfonic acid], poly[styrene-co-acrylamido-co-(2-chloroethylsulfonylmethyl)styrene-co-2-acrylamido-2-methylpropanesulfonic acid], poly(n-butyl acrylate-co-styrene-co-m+p-chloromethylstyrene-co-2-acrylamido-2-methylpropanesulfonic acid, poly[n-butyl acrylate-co-styrene-co-m+p-chloromethylstyrene-co-2-(methacryloyloxy)ethyltrimethylammonium methosulfate], and poly[styrene-co-acrylamide-co-(2-chloroethylsulfonylmethyl)styrene].
Claim 6
Dependent Claim 35 words
The composition of claim 3 wherein the fluorescent rare earth chelate comprises a rare earth and a chelating agent selected from the group consisting of 1,3-diketones; phthalates, naphthalates; dipyridines and terpyridines; p-benzoylbenzoates, p-benzoylacetonates, and phenanthralines.
Claim 7
Dependent Claim 144 words
In a method for performing an immunoassay with labeled immunoreagents, the improvement wherein the labeled immunoreagent is an antigen or antibody absorbed or covalently bound to an aqueous-stabilized fluorescent label comprising fluorescent rare earth chelate incorporated into a polymeric bead which is derived from a loaded latex, wherein said rare earth chelate comprises up to about 7.5 percent by weight of said beads and said loaded latex has a polymeric discontinuous phase which consists essentially of polymer polymerized from one or more ethenic monomers and has an aqueous continuous phase and exhibits essentially no visible coagulation or settling out when 250 ml of the latex containing from about 10 to about 20 weight percent dispersed phase is stirred at 25° C. into an equal volume of acetone over a 1 minute period and subsequently allowed to stand at about 25° C. for 10 minutes.
Claim 8
Dependent Claim 144 words
In a method for performing an immunoassay with labeled immunoreagents, the improvement wherein the labeled immunoreagent is an antigen or antibody absorbed or covalently bound to an aqueous-stabilized fluorescent label comprising fluorescent rare earth chelate incorporated into a polymeric bead which is derived from a loaded latex, wherein said rare earth chelate comprises up to about 7.5 percent by weight of said beads and said loaded latex has a polymeric discontinuous phase which consists essentially of polymer polymerized from one or more ethenic monomers and has an aqueous continuous phase and exhibits essentially no visible coagulation or settling out when 250 ml of the latex containing from about 10 to about 20 weight percent dispersed phase is stirred at 25° C. into an equal volume of acetone over a 1 minute period and subsequently allowed to stand at about 25° C. for 10 minutes.

References Cited (Backward Citations)

US3088875A Cited
US3551555A Cited
US3553310A Cited
US3853987A Cited
US4108972A Cited
US3939350A Cited
US4061466A Cited
DE2628158C3 Cited
US4020151A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-03-30 1984-09-29 1985-03-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-03-30 1988-09-29 1989-03-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-03-30 1992-09-29 1993-03-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag